Abeona Therapeutics (ABEO) Asset Utilization Ratio (2011 - 2026)

Abeona Therapeutics' Asset Utilization Ratio history runs 15 years deep, the most recent figure standing at 0.07 for Q1 2026.

• In Q1 2026, Asset Utilization Ratio changed N/A year-over-year to 0.07; the TTM figure through Mar 2026 stood at 0.07 (changed N/A YoY), while the FY2025 annual figure was 0.04, changed N/A from the prior year.
• Asset Utilization Ratio was 0.07 for Q1 2026 at Abeona Therapeutics, up from 0.03 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.23 in Q2 2022 to a low of 0.0 in Q3 2025.
• Historically, Asset Utilization Ratio has averaged 0.07 across 5 years, with a median of 0.05 in 2023.
• The sharpest annual moves came in 2023 and 2024: Asset Utilization Ratio tumbled 88.17% in 2023, then surged 177.5% in 2024.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.03 in 2022, then soared by 95.93% to 0.05 in 2023, then decreased by 6.3% to 0.05 in 2024, then tumbled by 48.77% to 0.03 in 2025, then surged by 169.31% to 0.07 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.07 (Q1 2026), 0.03 (Q4 2025), and 0.0 (Q3 2025), per Business Quant data.